Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -1.411% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) CN1CCN(S(=O)(=O)c2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCC3)c2)CC1
(b) N#C/C(C(=O)NCc1ccccc1)=C1/SC(Cc2ccc(Cl)cc2)C(=O)N1c1ccccc1
(c) C(=N/n1cnnc1)\c1ccc(N2CCOCC2)s1
(d) Cc1ccccc1N1CCN(C2CCCN(C(=O)CN3CCCC3=O)C2)CC1
Answer: a. CN1CCN(S(=O)(=O)c2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCC3)c2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(S(=O)(=O)c2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCC3)c2)CC1
CN1CCN(S(=O)(=O)c2cccc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCCC3)c2)CC1
3-(4-methylpiperazin-1-yl)sulfonyl-N-[2-pyrrolidin-1-yl-5-(trifluoromethyl)phenyl]benzamide